List of things you need to know while taking perampanel

When using perampanel tablets to treat epilepsy, there are key precautions in many aspects such as medication safety, drug interactions, and mental state monitoring.

Mental behavior monitoring cannot be ignored. Perampanel has a significant effect on the central nervous system. Adolescents and patients with a history of mental illness are more likely to develop aggressive behavior, anxiety, depression, hostility, self-injury tendencies and even suicidal ideation after taking the drug. Patients and their families should pay close attention to changes in mood and behavior, and seek medical attention immediately if abnormalities are found.

While taking this medication, be careful when driving and operating machinery. This drug may cause drowsiness, dizziness, and slow reaction, especially in the early stages of increasing the dosage. Therefore, it is not recommended to drive or operate dangerous machinery while taking the medication until it is confirmed that it does not affect relevant abilities.

Discontinuation of medication is also important. Perampanel should not be stopped suddenly, but should be gradually reduced, otherwise it may induce an increase in the frequency of epileptic seizures or severe seizures. High-dose users should reduce and stop slowly under the guidance of a doctor.

In terms of drug interactions, perampanel is mainly metabolized by the liverCYP3A enzyme. Co-administration of enzyme inducers (such as phenobarbital, carbamazepine, etc.) will reduce its plasma concentration, and the dose needs to be adjusted. The combined use of ethanol, sedatives, etc. will increase the central depressant effect, so combination should be avoided or carefully monitored.

Monitoring of liver and kidney function is also important. Some patients may experience elevated transaminases when taking the drug, and those with a history of liver disease should monitor their liver function regularly. It is contraindicated in patients with severe renal impairment due to limited safety data.

During pregnancy and breastfeeding, there is currently little relevant research data. Animal studies have not shown clear teratogenicity, but human data are insufficient. It should only be used when the potential benefits outweigh the risks. Women planning to become pregnant should weigh the pros and cons and use with caution or stop breastfeeding during lactation.

Medications for the elderly and children are different. The elderly have weak metabolic capacity and are more likely to have adverse reactions, so the dosage should be increased slowly; the data on use in children are limited, and the dosage needs to be adjusted strictly in accordance with the doctor's instructions.

In addition, although perampanel is not a traditional addictive drug, it has a certain potential for abuse, and patients should not increase the dosage or frequency on their own.

Reference materials:https://www.drugs.com/mtm/perampanel.html